Estratificación, monitorización y control del riesgo cardiovascular en pacientes con cáncer. Documento de consenso de SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC y AECC

García, Ana Martín; Mitroi, Cristina; Ramos, Pilar Mazón; Sanz, Ramón Garcí­a; Virizuela, Juan Antonio; Arenas, Meritxell; Cabello, Isabel Egocheaga; Albert, Dimpna C.; Sánchez, Manuel Anguita; Esteban, Vicente Ignacio Arrarte; Peña, Francisco Ayala de la; Lozano, C.; Castro, Almudena; Fernández, Antonio; Cosı́n-Sales, Juan; Chaparro-Muñoz, Marinela; Dalmau, Regina; Hernandez, Yasmin; Bronte, L. Deiros; Díez‐Villanueva, Pablo; Cervantes, C. Escobar; Redondo, Concepción Fernández; Rodríguez, Estíbaliz García; Lozano, Teresa; Vera, Pascual Marco; Monzonís, A. Martínez; Mesa, Dolores; Oristrell, Gerard; Gámiz, José Luis Palma; Pedreira, Milagros; Reinoso-Barbero, Luis; Rodríguez, Isabel; Antolín, José María Serrano; Toral, Belén; Royò, Laura Torres; Castillo, Sonia Velasco del; Vicente-Herrero, Teófila; Zataraín-Nicolás, Eduardo; Tamargo, Juan; Fernández, Teresa López

doi:10.1016/j.recesp.2020.11.014

Cited by 26 publications

(2 citation statements)

References 81 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Risk factors for RIHD are summarized in Table 2. Optimizing the management of cardiovascular risk factors (Table 3) and/or underlying heart disease may reduce the risk of cancer therapy-related cardiovascular events and the risk of early antitumoral treatment discontinuation [30][31][32][33].…”

Section: Baseline Risk Evaluationmentioning

confidence: 99%

Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies

Díaz-Gavela

Figueiras-Graillet²,

Ángel

et al. 2021

Cancers

Self Cite

View full text Add to dashboard Cite

In recent decades, improvements in breast cancer management have increased overall patient survival; however, many cancer therapies have been linked to an important risk of cardiovascular adverse events. Cardio-oncology has been proposed as an emerging specialty to coordinate preventive strategies that improve the cardiovascular health of oncologic patients. It employs the most suitable personalized multidisciplinary management approach for each patient to optimize their cardiovascular health and improve their survival and quality of life. Radiotherapy is an essential part of the therapeutic regimen in breast cancer patients but can also increase the risk of cardiovascular disease. Therefore, minimizing the negative impact of radiation therapy is an important challenge for radiotherapy oncologists and cardiologists specializing in this field. The aim of the present review is to update our knowledge about radiation-induced cardiotoxicity in breast cancer patients by undertaking a critical review of the relevant literature to determine risk prevention and control strategies currently available.

show abstract

Section: Baseline Risk Evaluationmentioning

confidence: 99%

Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies

Díaz-Gavela

Figueiras-Graillet²,

Ángel

et al. 2021

Cancers

Self Cite

View full text Add to dashboard Cite

show abstract

“…En este contexto, aparece la cardio-oncología con el objetivo de mejorar la salud cardiovascular del paciente y estudiar las interacciones entre la enfermedad oncológica y cardiovascular, tanto toxicidades como comorbilidades cardiacas (insuficiencia cardiaca, enfermedad coronaria, valvular, pericárdica, miocárdica y arritmias) (131). De hecho ya contamos con una publicación de documento de consenso de estratificación, monitorización y control del riesgo cardiovascular realizado en colaboración con diversas sociedades científicas (132).…”

Section: Toxicidad Cardiológica De La Inmunoterapiaunclassified

Valoración del miocardio mediante resonancia magnética cardiaca en pacientes en tratamiento activo con inhibidores de puntos de control inmunitario

Collado¹

View full text Add to dashboard Cite

Secuencias de inversión recuperación sensibles a la fase ponderada en T1 de respiración libre ACV Accidente cerebrovascular ADN Ácido desoxirribonucleico AIT Accidente isquémico transitorio AJCC American Joint Committee on Cancer ALK Quinasa del linfoma anaplásico APC Célula presentadora de antígeno. Del inglés, antigen-presenting cell ARA-II Antagonista de los receptores de angiotensina II BEM Biopsia endomiocárdica BNP Péptido natriurético cerebral. Del inglés, brain natriuretic peptide

show abstract

Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)

López‐Fernández

Vadillo

Guía

et al. 2021

Curr. Treat. Options in Oncol.

View full text Add to dashboard Cite

Estratificación, monitorización y control del riesgo cardiovascular en pacientes con cáncer. Documento de consenso de SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC y AECC

Cited by 26 publications

References 81 publications

Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies

Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies

Valoración del miocardio mediante resonancia magnética cardiaca en pacientes en tratamiento activo con inhibidores de puntos de control inmunitario

Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)

Contact Info

Product

Resources

About